🔗 Share this article

A shadow economy for unapproved weight-loss drugs is being driven by social media fitness personalities and vendors on communication apps, according to recent findings.

Investigational Drug Gaining Popularity Online

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its supposed weight-reducing effects. Followers are encouraged to contact these profiles directly for supplier links, while also receiving promotional offers.

Thriving Trade on Messaging Platforms

Additionally, a robust trade exists on messaging services, where groups with thousands of members share “before and after” photos, injection guides and claims of rapid British shipping. Vendors market the substance there before directing customers to WhatsApp for purchases.

Learning About The Experimental Drug

This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.

Medical Professionals Express Concerns

However, doctors and chemists have warned that the sale of what remains an unapproved medication in the United Kingdom is a cause for concern and could lead to users injecting products of uncertain source.

Some professionals stated the demand for the experimental drug could be linked to the rising price of approved slimming products such as Mounjaro.

Regulatory Status and Implementation

Marketing retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unapproved drug that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers try to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still breach pharmaceutical, advertising, and consumer regulations, risking fines, legal action or prison.

Service Response and Material Removal

Based on the social media company, the service has taken down problematic material and prohibited related keywords and search suggestions. The organization said it was committed to keeping the platform secure and allocating resources in strengthening enforcement strategies.

Digital Marketplace Activities

Research also found groups with up to nine thousand members marketing the experimental drug using Telegram's integrated search feature, which operates like a online catalog. Typing “retatrutide” instantly brings up groups with thousands of members, populated with images of slimming results, glowing testimonials and detailed instructions for preparing or administering at home.

After moments of joining one group, a vendor posted contact information, where most purchases take place. The vendor provided an instruction manual and promised shipping within 48 hours. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. Not one asked about body mass, medical conditions or previous experience.

Item Details and Costs

Inside these groups, posts show black plastic packages with postal service stickers, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at home with purified liquid, or ready-to-use injectors usually sold at £160 for 20mg. When asked how much time a injector should be used, sellers give contradictory responses ranging from a several days to “depends on your body”.

Platform Moderation and Safety Actions

A representative for Telegram said it actively monitored harmful content on its platform including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are administering substances they can’t verify. Although the research behind retatrutide is valid, these online versions may not include what they claim,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor linked the surge in demand to current price rises for approved slimming medications such as Mounjaro. “With prices rising, patients are turning to social media. But fake injections are highly dangerous. You can’t be certain what’s inside or whether the environment they were made in was clean,” she said.

Her team has already seen patients injured by personal administration from unverified sources. “We understand the frustration, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said the doctor. “These materials could be impure or improperly measured.”

Manufacturer Position

A spokesperson from Eli Lilly said retatrutide was in third stage clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this point no one can market [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a company experimental product not yet authorized … may expose patients to possibly significant medical dangers”.